- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 7.4 | 34.54 | 5.19 | 73.17 | 12.66 | 21.5 | N/A | - | ||
| 2024/9 | 5.5 | -36.07 | -16.47 | 65.78 | 13.57 | 22.22 | 0.73 | - | ||
| 2024/8 | 8.6 | 5.9 | 26.05 | 60.28 | 17.42 | 25.18 | 0.65 | - | ||
| 2024/7 | 8.12 | -4.04 | 22.68 | 51.68 | 16.09 | 23.7 | 0.69 | - | ||
| 2024/6 | 8.46 | 18.97 | 14.21 | 43.56 | 14.95 | 23.16 | 0.65 | - | ||
| 2024/5 | 7.11 | -6.13 | 11.95 | 35.1 | 15.12 | 21.26 | 0.7 | - | ||
| 2024/4 | 7.58 | 15.31 | 33.31 | 27.98 | 15.96 | 20.48 | 0.73 | - | ||
| 2024/3 | 6.57 | 3.88 | 7.35 | 20.4 | 10.61 | 20.4 | 0.78 | - | ||
| 2024/2 | 6.33 | -15.72 | 10.59 | 13.83 | 12.23 | 22.22 | 0.71 | - | ||
| 2024/1 | 7.51 | -10.53 | 13.66 | 7.51 | 13.66 | 22.45 | 0.71 | - | ||
| 2023/12 | 8.39 | 28.01 | 21.65 | 79.89 | -10.5 | 21.98 | 0.67 | - | ||
| 2023/11 | 6.55 | -6.79 | 5.29 | 71.5 | -13.2 | 20.17 | 0.73 | - | ||
| 2023/10 | 7.03 | 6.83 | 8.73 | 64.95 | -14.71 | 20.44 | 0.72 | - | ||
| 2023/9 | 6.58 | -3.52 | -12.28 | 57.92 | -16.88 | 20.02 | 0.71 | - | ||
| 2023/8 | 6.82 | 3.07 | -9.61 | 51.34 | -17.44 | 20.85 | 0.68 | - | ||
| 2023/7 | 6.62 | -10.66 | -7.17 | 44.51 | -18.52 | 20.38 | 0.7 | - | ||
| 2023/6 | 7.41 | 16.62 | -5.38 | 37.89 | -20.22 | 19.45 | 0.61 | - | ||
| 2023/5 | 6.35 | 11.76 | -50.82 | 30.48 | -23.15 | 18.16 | 0.66 | 因子公司杏昌生技去年同期有新增快篩試劑銷售本年度因疫情趨緩銷售減少 | ||
| 2023/4 | 5.68 | -7.13 | -4.67 | 24.13 | -9.79 | 17.53 | 0.68 | - | ||
| 2023/3 | 6.12 | 7.01 | -15.03 | 18.45 | -11.27 | 18.45 | 0.7 | - | ||
| 2023/2 | 5.72 | -13.38 | 6.95 | 12.32 | -9.27 | 19.22 | 0.67 | - | ||
| 2023/1 | 6.6 | -4.24 | -19.81 | 6.6 | -19.81 | 19.73 | 0.65 | - | ||
| 2022/12 | 6.9 | 10.79 | -14.11 | 89.28 | 8.55 | 19.59 | 0.68 | - | ||
| 2022/11 | 6.22 | -3.74 | -6.51 | 82.38 | 11.01 | 20.2 | 0.66 | - | ||
| 2022/10 | 6.47 | -13.81 | -17.23 | 76.15 | 12.73 | 21.52 | 0.62 | - | ||
| 2022/9 | 7.5 | -0.58 | -3.11 | 69.69 | 16.65 | 22.18 | 0.69 | - | ||
| 2022/8 | 7.55 | 5.85 | 0.3 | 62.18 | 19.6 | 22.51 | 0.68 | - | ||
| 2022/7 | 7.13 | -8.94 | 19.04 | 54.63 | 22.87 | 27.88 | 0.55 | - | ||
| 2022/6 | 7.83 | -39.38 | 10.7 | 47.5 | 23.46 | 26.72 | 0.52 | - | ||
| 2022/5 | 12.92 | 116.65 | 122.0 | 39.67 | 26.33 | 26.09 | 0.53 | 合併子公司杏昌生技業務增加 | ||
| 2022/4 | 5.96 | -17.22 | -14.0 | 26.75 | 4.57 | 18.52 | 0.75 | - | ||
| 2022/3 | 7.2 | 34.71 | 5.36 | 20.79 | 11.48 | 20.79 | 0.6 | - | ||
| 2022/2 | 5.35 | -35.06 | -6.59 | 13.58 | 15.03 | 21.61 | 0.58 | - | ||
| 2022/1 | 8.24 | 2.55 | 35.39 | 8.24 | 35.39 | 22.92 | 0.55 | - | ||
| 2021/12 | 8.03 | 20.59 | 22.38 | 82.24 | 24.88 | 22.5 | 0.64 | - | ||
| 2021/11 | 6.66 | -14.77 | 20.58 | 74.21 | 25.16 | 22.22 | 0.65 | 貿易出貨成長 | ||
| 2021/10 | 7.81 | 0.88 | 63.63 | 67.55 | 25.63 | 23.08 | 0.62 | 貿易營收成長 | ||
| 2021/9 | 7.75 | 2.91 | 35.93 | 59.74 | 21.93 | 21.26 | 0.62 | - | ||
| 2021/8 | 7.53 | 25.63 | 26.54 | 51.99 | 20.08 | 20.59 | 0.64 | 貿易出貨成長 | ||
| 2021/7 | 5.99 | -15.32 | 6.39 | 44.46 | 19.06 | 18.88 | 0.7 | - | ||
| 2021/6 | 7.07 | 21.55 | 15.45 | 38.48 | 21.3 | 19.83 | 0.6 | - | ||
| 2021/5 | 5.82 | -16.08 | 11.16 | 31.4 | 22.71 | 19.59 | 0.61 | - | ||
| 2021/4 | 6.93 | 1.41 | 37.67 | 25.58 | 25.68 | 19.5 | 0.61 | - | ||
| 2021/3 | 6.84 | 19.42 | 38.55 | 18.65 | 21.73 | 18.65 | 0.63 | 109年受疫情影響偏低 | ||
| 2021/2 | 5.73 | -5.86 | 28.89 | 11.81 | 13.74 | 18.37 | 0.64 | 109年2月因疫情影響，致營收明顯偏低。 | ||
| 2021/1 | 6.08 | -7.29 | 2.41 | 6.08 | 2.41 | 18.17 | 0.64 | - | ||
| 2020/12 | 6.56 | 18.81 | -9.48 | 65.85 | -8.87 | 16.86 | 0.64 | - | ||
| 2020/11 | 5.52 | 15.64 | 4.06 | 59.29 | -8.8 | 15.99 | 0.67 | - | ||
| 2020/10 | 4.77 | -16.19 | -10.35 | 53.77 | -9.95 | 16.42 | 0.66 | - | ||
| 2020/9 | 5.7 | -4.19 | -5.57 | 48.99 | -9.91 | 17.28 | 0.61 | - | ||
| 2020/8 | 5.95 | 5.63 | -9.26 | 43.29 | -10.45 | 17.7 | 0.6 | - | ||
| 2020/7 | 5.63 | -8.11 | -10.74 | 37.35 | -10.64 | 16.99 | 0.62 | - | ||
| 2020/6 | 6.13 | 17.03 | -2.75 | 31.72 | -10.62 | 16.4 | 0.58 | - | ||
| 2020/5 | 5.24 | 3.93 | -4.23 | 25.59 | -12.32 | 15.21 | 0.62 | - | ||
| 2020/4 | 5.04 | 2.06 | -20.4 | 20.35 | -14.18 | 14.41 | 0.65 | - | ||
| 2020/3 | 4.94 | 11.09 | -14.81 | 15.32 | -11.92 | 15.32 | 0.64 | - | ||
| 2020/2 | 4.44 | -25.19 | -0.91 | 10.38 | -10.47 | 17.63 | 0.55 | - | ||
| 2020/1 | 5.94 | -18.06 | -14.49 | 5.94 | -14.49 | 18.49 | 0.53 | - | ||
| 2019/12 | 7.25 | 36.59 | 14.83 | 72.26 | 4.39 | 0.0 | N/A | - | ||
| 2019/11 | 5.31 | -0.37 | -4.09 | 65.02 | 3.34 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 7.51 | 2023/1 | 6.6 | 2022/1 | 8.24 | 2021/1 | 6.08 | 2020/1 | 5.94 |
| 2024/2 | 6.33 | 2023/2 | 5.72 | 2022/2 | 5.35 | 2021/2 | 5.73 | 2020/2 | 4.44 |
| 2024/3 | 6.57 | 2023/3 | 6.12 | 2022/3 | 7.2 | 2021/3 | 6.84 | 2020/3 | 4.94 |
| 2024/4 | 7.58 | 2023/4 | 5.68 | 2022/4 | 5.96 | 2021/4 | 6.93 | 2020/4 | 5.04 |
| 2024/5 | 7.11 | 2023/5 | 6.35 | 2022/5 | 12.92 | 2021/5 | 5.82 | 2020/5 | 5.24 |
| 2024/6 | 8.46 | 2023/6 | 7.41 | 2022/6 | 7.83 | 2021/6 | 7.07 | 2020/6 | 6.13 |
| 2024/7 | 8.12 | 2023/7 | 6.62 | 2022/7 | 7.13 | 2021/7 | 5.99 | 2020/7 | 5.63 |
| 2024/8 | 8.6 | 2023/8 | 6.82 | 2022/8 | 7.55 | 2021/8 | 7.53 | 2020/8 | 5.95 |
| 2024/9 | 5.5 | 2023/9 | 6.58 | 2022/9 | 7.5 | 2021/9 | 7.75 | 2020/9 | 5.7 |
| 2024/10 | 7.4 | 2023/10 | 7.03 | 2022/10 | 6.47 | 2021/10 | 7.81 | 2020/10 | 4.77 |
| N/A | N/A | 2023/11 | 6.55 | 2022/11 | 6.22 | 2021/11 | 6.66 | 2020/11 | 5.52 |
| N/A | N/A | 2023/12 | 8.39 | 2022/12 | 6.9 | 2021/12 | 8.03 | 2020/12 | 6.56 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 24Q3 (20) | 0.43 | -4.44 | 10.26 |
| 24Q2 (19) | 0.45 | 9.76 | 55.17 |
| 24Q1 (18) | 0.41 | 32.26 | 78.26 |
| 23Q4 (17) | 0.31 | -20.51 | 55.0 |
| 23Q3 (16) | 0.39 | 34.48 | 34.48 |
| 23Q2 (15) | 0.29 | 26.09 | 11.54 |
| 23Q1 (14) | 0.23 | 15.0 | 4.55 |
| 22Q4 (13) | 0.2 | -31.03 | -20.0 |
| 22Q3 (12) | 0.29 | 11.54 | 26.09 |
| 22Q2 (11) | 0.26 | 18.18 | 23.81 |
| 22Q1 (10) | 0.22 | -12.0 | -18.52 |
| 21Q4 (9) | 0.25 | 8.7 | -13.79 |
| 21Q3 (8) | 0.23 | 9.52 | 27.78 |
| 21Q2 (7) | 0.21 | -22.22 | 23.53 |
| 21Q1 (6) | 0.27 | -6.9 | 68.75 |
| 20Q4 (5) | 0.29 | 61.11 | 26.09 |
| 20Q3 (4) | 0.18 | 5.88 | 0.0 |
| 20Q2 (3) | 0.17 | 6.25 | 0.0 |
| 20Q1 (2) | 0.16 | -30.43 | 0.0 |
| 19Q4 (1) | 0.23 | 0.0 | 0.0 |
